Introduction: The interrelation between cardiovascular diseases (CVDs) and renal dysfunction and the beneficial role of nutraceuticals are worthy to be studied. Nutraceuticals with anticancer effects are gaining great importance. The aim of this research was studying the anti-cancer, CVDs prevention and renal dysfunction properties of γ-oryzanol (γ-O) and rice bran oil/γ-O mixture (RBO/γ-O) as nutraceuticals. Methods: Rats were divided into 7 groups. Group 1 was fed on balanced diet and served as normal control (NC). Group 2 consumed high-fat-sucrose diet (HFSD) as CVD control. Groups 3 and 4 were fed on HFSD and treated by γ-O and RBO/γ-O, respectively. Group 5 was maintained on HFSD with cisplatin injection (cardiorenal syndrome control) (CRSC). Groups 6 and 7 were treated like group 5 and given either γ-O or RBO/γ-O. Plasma lipid profile, malondialdehyde (MDA), tumor necrosis factor-α (TNF-α), catalase activity, creatinine and urea were determined besides urinary creatinine clearance. Nutraceuticals’ anticancer effect was assessed in hepatocellular carcinoma cell (HepG2) line. Results: Significant increases (P < 0.05) in lipid parameters with reduction of high-density lipoprotein cholesterol (HDL-C) were noticed in CVD control compared to NC group; the same changes were demonstrated in CRSC with lesser extent. In CVD control and CRSC groups; a significant increase (P < 0.05) in MDA and TNF-α with a reduction in catalase were noticed. Kidney dysfunction was demonstrated in the CRSC group. Administration of both RBO/γ-O and γ-O produced variable improvements in all parameters in both models and had anticancer effects. Conclusion: RBO/γ-O and γ-O had protective effects on CVDs and cardiorenal syndrome as well as anti-hepatocellular carcinoma activities with superiority of RBO/γ-O.
Introduction: Parkinson’s disease (PD) is a neurodegenerative disease with a prevalence of 1% in the elderly worldwide. The aim of the research is to study the interrelationship of iron status, the immune system including inflammatory cytokines, brain divalent metal transporter 1 (DMT1), and dopamine receptors D1 (DRD1) in a PD rat model. The potential protective effects of grape seed and green coffee bean ethanol extracts and quercetin were also studied. Methods: Phenolic and flavonoid contents of grape seed and green coffee bean and in vitro free radicals scavenging activities of the extracts and quercetin were determined. Male rats were divided into five groups. Group 1 served as normal control (NC), group 2 represented Parkinsonian control (PC). Groups 3, 4, and 5 were the test groups treated by daily oral green coffee bean, grape seed extracts, and quercetin, respectively. PD was induced by rotenone in groups 2 to 5. Brain oxidative stress, DMT1, and DRD1 expressions, and histopathology were assessed. Parameters of the immune system, represented by plasma interferon-gamma (IFNγ) and CD4, and brain tumor necrosis factor-alpha (TNF-α) along with iron status were also determined. Results: Phenolic and flavonoid contents of green coffee bean were high compared to grape seed (P < 0.05). Quercetin experienced the highest in-vitro free radicals scavenging activities. Iron deficiency anemia, together with elevated IFNγ, TNF-α, DMT1 expressions, and brain malondialdehyde (MDA) were demonstrated in PC compared to NC (P < 0.05). Also, reduction in CD4 and brain reduced-glutathione (GSH) (P < 0.05) were noticed in PC with brain histopathological alterations. Different treatments showed variable improvements in the majority of parameters (P < 0.05) and brain histopathology. Conclusion: Iron deficiency anemia might result from cytokine elevation in PD. Reduced DRD1 and altered immune system including cytokines together with increased brain DMT1 might induce neurodegeneration in PD. Different treatments showed variable neuroprotective effects through modulation of inflammation, oxidative stress, immune system, iron status, DMT1, and DRD1.
Background:
Diarrhea and malnutrition are major health problems in developing countries. Inflammation, high
oxidative stress, poor nutritional status and fatty liver were encountered during such diseases. Patents for diarrhea
and malnutrition management (WO2007/130882A2, WO00/37106A1, WO2014/152420 and CA2987364A1) were
published.
Objective:
The objective was to introduce anti-diarrhea functional foods with preventive effect on
malnutrition.
Methods:
Two processing techniques were applied for preparing functional foods (formula 1
ingredients were made into cookies followed by grinding; formula 2 ingredients were pre-cooked, dried and mixed
in powder form) that evaluated in rat model of diarrhea with malnutrition (DM). Formula 2 was also assessed when
mixed with nucleotides. The ingredients were edible plants possess anti-diarrheal effect with high protein sources
(legumes and casein).
Results:
Induction of diarrhea with malnutrition, high oxidative stress, inflammation,
accumulation of liver fat and histopathological changes were demonstrated in DM control compared to normal
control. The functional foods produced variable improvement in growth curves, food efficiency ratio, hemoglobin,
hematocrit and plasma zinc, protein, albumin, globulin, lipase activity and MDA. Formula 1 showed superior in
improving intestinal histopathology while formula 2 was more efficient in elevating plasma iron. Formula 2 with
nucleotides was the best in improving growth curves, alkaline phosphatase and reducing liver fat. Intestinal mucosa
reduced glutathione and nitrite showed efficient significant reduction on treatment with formula 2 with or without
nucleotides. The formulas showed anti-diarrheal effect through improving feces weight and moisture content.
Conclusion:
Studied functional foods showed anti-diarrheal effect and malnutrition improvement with different
degrees.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.